BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16943560)

  • 1. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.
    Prickaerts J; Moechars D; Cryns K; Lenaerts I; van Craenendonck H; Goris I; Daneels G; Bouwknecht JA; Steckler T
    J Neurosci; 2006 Aug; 26(35):9022-9. PubMed ID: 16943560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
    Bersudsky Y; Shaldubina A; Kozlovsky N; Woodgett JR; Agam G; Belmaker RH
    Behav Pharmacol; 2008 May; 19(3):217-24. PubMed ID: 18469539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
    Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
    Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.
    O'Brien WT; Harper AD; Jové F; Woodgett JR; Maretto S; Piccolo S; Klein PS
    J Neurosci; 2004 Jul; 24(30):6791-8. PubMed ID: 15282284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
    Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
    Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3beta affects size of dentate gyrus and species-typical behavioral tasks in transgenic and knockout mice.
    Kondratiuk I; Devijver H; Lechat B; Van Leuven F; Kaczmarek L; Filipkowski RK
    Behav Brain Res; 2013 Jul; 248():46-50. PubMed ID: 23570858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of glycogen synthase kinase-3-beta activity leads to abnormalities in physiological measures in mice.
    Ahnaou A; Drinkenburg WH
    Behav Brain Res; 2011 Aug; 221(1):246-52. PubMed ID: 21392539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex.
    Szymańska M; Suska A; Budziszewska B; Jaworska-Feil L; Basta-Kaim A; Leśkiewicz M; Kubera M; Gergont A; Kroczka S; Kaciński M; Lasoń W
    Pharmacol Rep; 2009; 61(4):612-20. PubMed ID: 19815943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
    Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
    Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats.
    Fang ZH; Lee CH; Seo MK; Cho H; Lee JG; Lee BJ; Park SW; Kim YH
    Neurosci Res; 2013 Aug; 76(4):187-94. PubMed ID: 23665137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.
    Kirshenboim N; Plotkin B; Shlomo SB; Kaidanovich-Beilin O; Eldar-Finkelman H
    J Mol Neurosci; 2004; 24(2):237-45. PubMed ID: 15456937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sevoflurane attenuates stress-enhanced fear learning by regulating hippocampal BDNF expression and Akt/GSK-3β signaling pathway in a rat model of post-traumatic stress disorder.
    Chen C; Ji M; Xu Q; Zhang Y; Sun Q; Liu J; Zhu S; Li W
    J Anesth; 2015 Aug; 29(4):600-8. PubMed ID: 25533726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.
    Kozikowski AP; Gunosewoyo H; Guo S; Gaisina IN; Walter RL; Ketcherside A; McClung CA; Mesecar AD; Caldarone B
    ChemMedChem; 2011 Sep; 6(9):1593-602. PubMed ID: 21732538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF-GSK-3β-β-Catenin Pathway in the mPFC Is Involved in Antidepressant-Like Effects of Morinda officinalis Oligosaccharides in Rats.
    Xu LZ; Xu DF; Han Y; Liu LJ; Sun CY; Deng JH; Zhang RX; Yuan M; Zhang SZ; Li ZM; Xu Y; Li JS; Xie SH; Li SX; Zhang HY; Lu L
    Int J Neuropsychopharmacol; 2017 Jan; 20(1):83-93. PubMed ID: 27729466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice.
    Freitas AE; Machado DG; Budni J; Neis VB; Balen GO; Lopes MW; de Souza LF; Dafre AL; Leal RB; Rodrigues AL
    Behav Brain Res; 2013 Jan; 237():176-84. PubMed ID: 23018126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.
    Du J; Wei Y; Liu L; Wang Y; Khairova R; Blumenthal R; Tragon T; Hunsberger JG; Machado-Vieira R; Drevets W; Wang YT; Manji HK
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11573-8. PubMed ID: 20534517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta.
    Kitazawa M; Trinh DN; LaFerla FM
    Ann Neurol; 2008 Jul; 64(1):15-24. PubMed ID: 18318434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.